Diabetes-Metabolism Research and Reviews
Leading citation impact metric from Clarivate Journal Citation Reports
papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 8.3) | 🔵 Computed |
| 2025 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 6) | 🔵 Computed |
| 2023 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 8) | 🔵 Computed |
| 2021 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4.876) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Diabetes/Metabolism Research and Reviews is an indispensable resource for clinicians and researchers working in the fields of diabetes, endocrinology, metabolism and obesity. Our reviews section provides the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians. Original articles describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care.
SCImago & Scopus Journal Intelligence
Not indexed in SCImago / Scopus databaseThis journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
ENDOCRINOLOGY & METABOLISM | JCRSCIE | 15/198 | Q1 |
ENDOCRINOLOGY & METABOLISM | JCISCIE | 25/198 | Q1 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 120 | 66 |
| 2025 | 6 | 108 | 475 |
| 2024 | — | 118 | 1,177 |
| 2023 | 8 | 159 | 4,525 |
| 2022 | — | 99 | 1,465 |
| 2021 | 4.876 | 92 | 2,723 |
| 2020 | — | 187 | 11,287 |
| 2019 | — | 153 | 5,099 |
| 2018 | — | 158 | 4,998 |
| 2017 | — | 107 | 3,141 |
| 2016 | — | 128 | 3,873 |
| 2015 | — | 138 | 8,312 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Diabetes-Metabolism Research and Reviews
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics